Both in Pharmaceuticals
AB Corporate Bond ETF vs Innovator U.S. Equity Ultra Buffer ETF - November
Over the past year EYEG returned −7.6% and UNOV returned +10.4%; their daily moves had a correlation of 0.41.
EYEG −7.6% UNOV +10.4%Growth of $1, one year, split-adjusted
| Metric | EYEG | UNOV |
|---|---|---|
| Price | $33.45 | $41.36 |
| Market cap | $26.8M | $106.5M |
| Today | −0.61% | −0.24% |
| 1 month | −3.6% | +0.6% |
| 6 months | −4.2% | +12.4% |
| Year to date | −6.5% | +8.7% |
| 1 year | −7.3% | +10.7% |
| Revenue growth (YoY) | — | +3.0% |
| Gross margin | — | 69.0% |
| Net margin | — | 8.0% |
| P/E (TTM) | — | 27.4× |
| Price / sales | — | 3.0× |
| Net cash | $16.8M | $2.8M |
| Dividend yield | 4.61% | — |
| Volatility (60d) | 5.0% | 5.1% |
| Short % of float | — | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).